Literature DB >> 9329339

Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.

E Leibenluft1, P J Schmidt, E H Turner, M A Danaceau, S B Ashman, T A Wehr, D R Rubinow.   

Abstract

The possible role of gonadal steroids in regulating sleep and circadian rhythms in humans has received relatively little attention despite the importance of the topic to several clinical syndromes. Pharmacologically induced hypogonadism, with and without gonadal steroid replacement, provides an opportunity to examine these questions within a controlled experimental design. We used leuprolide acetate, with and without testosterone replacement, to study the role of testosterone in the regulation of sleep and of melatonin, PRL, and TSH secretion in men. Results from 10 men revealed significant decreases in 24-h PRL levels and in the percentage and time of stage 4 sleep in the hypogonadal state compared with testosterone replacement. There were no differences in melatonin or TSH secretion or in the timing or duration of sleep between the two hormonal conditions. These results indicate that testosterone has relatively specific and discrete effects on sleep and hormonal rhythms in men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329339     DOI: 10.1210/jcem.82.10.4270

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

Review 1.  A closed literature-based discovery technique finds a mechanistic link between hypogonadism and diminished sleep quality in aging men.

Authors:  Christopher M Miller; Thomas C Rindflesch; Marcelo Fiszman; Dimitar Hristovski; Dongwook Shin; Graciela Rosemblat; Han Zhang; Kingman P Strohl
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

2.  Effects of anabolic androgenic steroids on sleep patterns of individuals practicing resistance exercise.

Authors:  Daniel Paulino Venâncio; Sergio Tufik; Silvério Aparecido Garbuio; Antonio Claudio Lucas da Nóbrega; Marco Túlio de Mello
Journal:  Eur J Appl Physiol       Date:  2007-11-28       Impact factor: 3.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.